Literature DB >> 20402670

Biofilm formation by Streptococcus pneumoniae isolates from paediatric patients.

Terhi Tapiainen1, Tiia Kujala, Tarja Kaijalainen, Irma Ikäheimo, Annika Saukkoriipi, Marjo Renko, Jarmo Salo, Maija Leinonen, Matti Uhari.   

Abstract

The clinical significance of pneumococcal biofilm formation is largely unknown. To clarify this, we tested whether the ability of pneumococcal clinical isolates to form biofilm in vitro accounts for the diverse clinical outcomes. Clinical pneumococcal isolates were cultured from the nasopharynx (n=106), middle ear effusion (n=43) and blood (n=55) of 204 children altogether. Biofilm formation, assessed by measuring optical density (OD) values in microtitre plates after crystal violet staining, did not differ between the bacteria from different sources (p=0.18), the mean OD values of the isolates being 0.119 [95% confidence interval (CI) 0.100-0.138] in the nasopharynx samples, 0.094 (95% CI 0.069-0.119) in the acute otitis media cases, 0.109 (95% CI 0.077-0.141) in the secretory otitis media cases, 0.122 (95% CI 0.084-0.160) in those with sepsis and 0.175 (95% CI 0.071-0.280) in those with other invasive infections. Serotypes 33 and 14 were the most efficient in forming biofilms, whereas serotypes 3 and 38 were poor biofilm producers. We conclude that the clinical presentation of pneumococcal disease did not differ in relation to biofilm formation in vitro, even though there was marked variation between the clinical isolates and serotypes.

Entities:  

Mesh:

Year:  2010        PMID: 20402670     DOI: 10.1111/j.1600-0463.2010.02587.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  10 in total

1.  Pneumococcal interactions with epithelial cells are crucial for optimal biofilm formation and colonization in vitro and in vivo.

Authors:  Laura R Marks; G Iyer Parameswaran; Anders P Hakansson
Journal:  Infect Immun       Date:  2012-05-29       Impact factor: 3.441

2.  Contribution of serotype and genetic background to biofilm formation by Streptococcus pneumoniae.

Authors:  R Camilli; A Pantosti; L Baldassarri
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-16       Impact factor: 3.267

3.  Antibiotic activity against naive and induced Streptococcus pneumoniae biofilms in an in vitro pharmacodynamic model.

Authors:  Nathalie M Vandevelde; Paul M Tulkens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2013-12-16       Impact factor: 5.191

4.  High levels of genetic recombination during nasopharyngeal carriage and biofilm formation in Streptococcus pneumoniae.

Authors:  Laura R Marks; Ryan M Reddinger; Anders P Hakansson
Journal:  MBio       Date:  2012-09-25       Impact factor: 7.867

5.  Prophage spontaneous activation promotes DNA release enhancing biofilm formation in Streptococcus pneumoniae.

Authors:  Margarida Carrolo; Maria João Frias; Francisco Rodrigues Pinto; José Melo-Cristino; Mário Ramirez
Journal:  PLoS One       Date:  2010-12-20       Impact factor: 3.240

6.  Streptococcus pneumoniae in biofilms are unable to cause invasive disease due to altered virulence determinant production.

Authors:  Carlos J Sanchez; Nikhil Kumar; Anel Lizcano; Pooja Shivshankar; Julie C Dunning Hotopp; James H Jorgensen; Hervé Tettelin; Carlos J Orihuela
Journal:  PLoS One       Date:  2011-12-08       Impact factor: 3.240

Review 7.  Biofilm formation in Streptococcus pneumoniae.

Authors:  Mirian Domenech; Ernesto García; Miriam Moscoso
Journal:  Microb Biotechnol       Date:  2011-09-09       Impact factor: 5.813

8.  Nonencapsulated Streptococcus pneumoniae Cause Acute Otitis Media in the Chinchilla That Is Enhanced by Pneumococcal Surface Protein K.

Authors:  Lance E Keller; Jessica Friley; Cheshil Dixit; Moon H Nahm; Larry S McDaniel
Journal:  Open Forum Infect Dis       Date:  2014-07-01       Impact factor: 3.835

Review 9.  Streptococcus pneumoniae biofilm formation and dispersion during colonization and disease.

Authors:  Yashuan Chao; Laura R Marks; Melinda M Pettigrew; Anders P Hakansson
Journal:  Front Cell Infect Microbiol       Date:  2015-01-13       Impact factor: 5.293

Review 10.  Microbiological Aspects of Acute and Chronic Pediatric Rhinosinusitis.

Authors:  Lorenzo Drago; Lorenzo Pignataro; Sara Torretta
Journal:  J Clin Med       Date:  2019-01-28       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.